Ranbaxy Pharmaceuticals Canada said that RAN-Atorvastatin is expected to be made available to all Canadian patients under the Ranbaxy label, subject to provincial formulary listings. Atorvastatin is an
Patrys said that an application for approval to commence a human clinical trial for PAT-SM6 has been lodged with Australian authorities, with the aim of initiating the trial
MS Workstation 7 features Scheduled Multiple-Reaction Monitoring (s-MRM), which facilitates method development, maintenance and data reduction tasks for challenging multi-component methods. Bruker has said that to answer the
Ablynx said that this is the first lead candidate emerging from the Alzheimer’s disease collaboration between Ablynx and Boehringer Ingelheim and is expected to result in a EUR2m
Ipilimumab is a T-cell potentiator that specifically blocks the inhibitory signal of CTLA-4 (cytotoxic T lymphocyte-associated antigen 4), a molecule on T-cells that plays a critical role in
According to Quanterix, researchers have developed a simple blood test using its Single Molecule Array (SiMoA) technology to selectively capture and measure individual Prostate Specific Antigen (PSA) molecules
Bayer HealthCare said that the results of the study of investigational drug gadobutrol met all of its pre-specified primary efficacy objectives. Gadobutrol is investigational in the US and
LUX-Lung 2 is part of the comprehensive LUX-Lung clinical trial programme. Currently, the clinical trial programme comprises more than ten trials conducted across the globe. LUX-Lung 2 is
GSK Rotarix is a two-dose, orally-administered vaccine that offers protection against rotavirus to infants and children. Reportedly, more than 69 million doses of the vaccine have been distributed
Spectrum Chemicals & Laboratory Products manufactures and distributes fine chemicals and laboratory products. Spectrum’s chemical offering consists of over 15,000 active pharmaceutical ingredients (API’s), excipients, biochemicals, nutraceuticals, cosmetic
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.